These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27458622)

  • 1. [Cardiovascular disease in rheumatic diseases].
    Nasonov EL; Popkova TV; Novikova DS
    Ter Arkh; 2016; 88(5):4-12. PubMed ID: 27458622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research.
    Gasparyan AY; Ayvazyan L; Cocco G; Kitas GD
    Curr Pharm Des; 2012; 18(11):1543-55. PubMed ID: 22364138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of cardiovascular risk factors].
    Krüger K
    Z Rheumatol; 2016 Mar; 75(2):173-80; quiz 181-2. PubMed ID: 26924198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases.
    Manolis AS; Tzioufas AG
    Curr Vasc Pharmacol; 2020; 18(6):533-537. PubMed ID: 32693768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary complications of biological therapies in children and adults with rheumatic diseases.
    Nisar MK; Ostör AJ
    Paediatr Respir Rev; 2013 Dec; 14(4):236-41. PubMed ID: 23462434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopause and Rheumatic Disease.
    Talsania M; Scofield RH
    Rheum Dis Clin North Am; 2017 May; 43(2):287-302. PubMed ID: 28390570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis.
    Nandi P; Kingsley GH; Scott DL
    Curr Opin Rheumatol; 2008 May; 20(3):251-6. PubMed ID: 18388514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic agents therapy for Saudi children with rheumatic diseases: indications and safety.
    Al-Mayouf SM; Alenazi A; AlJasser H
    Int J Rheum Dis; 2016 Jun; 19(6):600-5. PubMed ID: 24730661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of influenza-like illness into a cohort of patients affected by chronic inflammatory rheumatism and treated with biological agents.
    Bello SL; Serafino L; Bonali C; Terlizzi N; Fanizza C; Anecchino C; Lapaldula G
    Reumatismo; 2012 Dec; 64(5):299-306. PubMed ID: 23256105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic journey of biologic agents: There will be an end?
    Atzeni F; Sarzi-Puttini P
    Pharmacol Res; 2019 Sep; 147():104340. PubMed ID: 31276775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacotherapy in pregnancy and lactation in rheumatic diseases].
    Anić B; Cikes N
    Reumatizam; 2006; 53(2):55-8. PubMed ID: 17580555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biologics and cardiovascular risk].
    Tarner IH; Müller-Ladner U; Hamm C
    Z Rheumatol; 2010 Oct; 69(8):702-6, 708-11. PubMed ID: 20862482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biologics and further new drugs for rheumatic diseases since 2000].
    Krüger K
    Orthopade; 2018 Nov; 47(11):906-911. PubMed ID: 30280235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective review of the adverse effects of biological therapy and reasons for its discontinuation in a resource-limited setting.
    Rood JW; Du Toit R
    S Afr Med J; 2020 Nov; 110(12):1231-1237. PubMed ID: 33403971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of Treatments for Pediatric Rheumatic Diseases.
    Higgins GC
    Pediatr Clin North Am; 2018 Aug; 65(4):827-854. PubMed ID: 30031500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors, fitness and physical activity in rheumatic diseases.
    Turesson C; Matteson EL
    Curr Opin Rheumatol; 2007 Mar; 19(2):190-6. PubMed ID: 17278937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis.
    Di Minno MN; Iervolino S; Lupoli R; Russolillo A; Coppola A; Peluso R; Scarpa R; Di Minno G
    Semin Thromb Hemost; 2012 Jul; 38(5):497-505. PubMed ID: 22399309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rheumatic diseases during pregnancy].
    Fischer-Betz R
    Internist (Berl); 2012 Sep; 53(9):1047-53. PubMed ID: 22695896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.
    Mason JC; Libby P
    Eur Heart J; 2015 Feb; 36(8):482-9c. PubMed ID: 25433021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics in the rheumatic diseases.
    Cronstein BN
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):16-9. PubMed ID: 17121484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.